Sepsis remains one of the most time-critical medical emergencies faced by healthcare professionals. Early recognition, prompt treatment and access to reliable diagnostic information are essential to improving patient outcomes. The latest NICE Guideline NG253: Suspected Sepsis in People Aged 16 or Over - Recognition, Assessment and Early Management reinforces the importance of structured clinical assessment, risk stratification and timely intervention in patients with suspected sepsis. One diagnostic tool attracting increasing attention is Procalcitonin (PCT), a biomarker that may help clinicians assess the likelihood of bacterial infection and support antimicrobial stewardship programmes. While PCT should never be used in isolation to diagnose or exclude sepsis, it can provide valuable additional information when interpreted alongside clinical findings and other diagnostic investigations.

Healthcare systems are under growing pressure to deliver faster diagnoses, improve patient outcomes, and reduce costs. In this environment, multi-test point-of-care (POC) analysers are emerging as valuable tools that bring laboratory-quality testing directly to the patient.

HbA1c testing is essential. FIAPro makes it effortless.

In the evolving landscape of acute cardiac care, time is still the most precious clinical resource. For patients presenting with chest pain or symptoms suggestive of an acute coronary syndrome (ACS), prompt and accurate diagnosis can mean the difference between early discharge and life-saving intervention. This is where high-sensitivity Troponin-I (hs-cTnI) assays are proving their worth and why point-of-care (POC) testing solutions like the FIAPro immunofluorescence analyser, are gaining traction.

Sussex Biologicals Limited is pleased to announce the addition of the FIAPro™ Immunofluorescence Analyser to its diagnostic portfolio - a compact, quantitative/qualitative POCT platform designed to support a broad range of clinical pathways.

A new oral spray vaccine shows promise against recurrent UTIs, keeping half of participants infection-free for 9 years!

Skip the GP! New campaign empowers women with UTIs to get direct treatment from pharmacists, saving time, money, and antibiotics.